Physician profile
Julia Freund
NPI 1780313288
$1,962.95
in general payments reported to CMS, 2019-2025
17 companies · $709 in 2025
The $709 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $63.01 · 2023: $393 · 2024: $798 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,899.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $350.72 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $317.53 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $292.86 | 2023-2025 | |
| Lilly USA, LLC | $227.07 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Amgen INC. | $218.82 | 2023-2025 | Evenity, Otezla, Repatha |
| Pfizer INC. | $135.34 | 2023-2025 | |
| Glaxosmithkline, LLC. | $114.77 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Novartis Pharmaceuticals Corporation | $70.23 | 2022-2025 | |
| Kowa Pharmaceuticals America, INC. | $63.37 | 2023-2025 | Zoryve, Livalo, Seglentis |
| Exact Sciences Corporation | $47.61 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi Pasteur INC. | $22.66 | 2024 | |
| Esperion Therapeutics, INC. | $19.57 | 2025 | Nexletol |
| Xeris Pharmaceuticals, INC. | $18.62 | 2025 | Gvoke Hypopen |
| Idorsia Pharmaceuticals US INC | $16.42 | 2023 | Quviviq |
| Hikma Pharmaceuticals USA | $16.38 | 2023 | Mitigare |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.25 | 2023 | Gardasil 9, Vaxneuvance, Vaxelis |
| Lundbeck LLC | $14.73 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Freund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.